Successful Add-on Vortioxetine for an Adolescent With Attention-Deficit/Hyperactivity Disorder.

To the EditorsAttention-deficit/hyperactivity disorder (ADHD) is one of the most commonly encountered child/adolescent psychiatry disorders in clinical practice with a worldwide prevalence of circa 5%. Stimulants are first-line treatment modality in the guidelines of ADHD pharmacotherapy. Neverthele

• Publication year

  2018

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  2018-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/JCP.0000000000000912PMID 29912797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders

  2017cited by this paper
• Catatonia is a systemic medical syndrome

  2016cited by this paper
• Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more

  2016cited by this paper
• Duloxetine Alleviates Stimulant Dysphoria, Helps With Enuresis, and Complements Cognitive Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder.

  2016cited by this paper
• Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters

  2015cited by this paper
• Hypercalcemia and "primary" hyperparathyroidism during lithium therapy.

  2015cited by this paper
• Lithium-induced neurotoxicity: clinical presentations, pathophysiology, and treatment.

  2014cited by this paper
• Clozapine-withdrawal catatonia.

  2009cited by this paper
• Lithium toxicity presenting as catatonia in an adolescent girl.

  2007cited by this paper
• The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity

  2005cited by this paper
• Catatonia: A Clinician’s Guide to Diagnosis and Treatment

  2004cited by this paper
• Acute catatonia after a single dose of ecstasy.

  2002cited by this paper
• Benzodiazepine withdrawal-induced catatonia.

  2001cited by this paper
• Is the EEG helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature.

  2000cited by this paper
• Catatonia. I. Rating scale and standardized examination

  1996cited by this paper
• Neuroleptic‐induced Catatonia After Abrupt Withdrawal of Amantadine During Neuroleptic Therapy

  1986cited by this paper
• Age, dementia, dyskinesias, and lithium response.

  1980cited by this paper
• Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.

  1976cited by this paper
• Lithium carbonate, haloperidol, and irreversible brain damage.

  1974cited by this paper

• Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases

  2021cites this paper
• Recurrent Suicidal Ideation During Intravenous Ketamine Treatment.

  2019cites this paper
• Successful Vortioxetine Monotherapy for an Adolescent With Treatment-Resistant Obsessive-Compulsive Disorder.

  2019cites this paper
• Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad?

  2019cites this paper
• Add-on Milnacipran Boosts Methylphenidate Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety and Enuresis.

  2019cites this paper
• Mirtazapine for Major Depression Developed After Hyperemesis Gravidarum.

  2018cites this paper